Bioenergy Life Science, Inc.’s ingredient Bioenergy Ribose® (D-Ribose) has received a positive opinion from the European Food Safety Authority (EFSA) for ‘the safety of use’ as a novel food (NF) ingredient.
Bioenergy Life Science, Inc. (BLS) welcomed this news today (May 31) in a published result of the EFSA evaluation of its core ingredient D-Ribose. (EFSA Journal 2018;16(5):5265). EFSA concludes that D-Ribose is safe for the general population including children and that this relates to a value of 36 mg/kg/day, which for a 70Kg adult is equivalent to a daily dosage of 2.5g, which is a strong dose for efficacy.
"We have worked very hard for this achievement and are very happy we have the safety approval from EFSA to use Bioenergy Ribose in food and beverage applications in the EU," states Marianne McDonagh, vice-president of Sales at BLS.
Bioenergy Ribose has been used in dietary supplements for nearly 30 years in Europe. Its use in the US, where it is FDA GRAS-certified, extends over 40 years and includes sports nutrition and functional food and beverage applications. Its health enhancing benefits have been experienced by millions of users.
"We look forward to continue working with the EU Commission to define the list of food categories and expanding our brand and core product, Bioenergy Ribose, in Europe," says McDonagh.
For the complete report, please follow this link: www.efsa.europa.eu/en/efsajournal/pub/5265.